Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN966282 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Hepatocyte Growth Factor (Hepapoietin A, Scatter Factor) (HGF) (N-Term) antibody
- Antibody type
- Polyclonal
- Antigen
- A synthetic peptide corresponding to a sequence at the N-terminal of human HGF, different from the related mouse sequence by two amino acids.< br/>Immunogen was affinity purified.
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- N-Term
- Isotype
- IgG
- Vial size
- 100 μg
- Storage
- At -20°C for one year. After reconstitution, at 4°C for one month. It can also be aliquotted and stored frozen at -20°C for a longer time.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Localisation of hepatocyte growth factor and its receptor (c-met) protein and mRNA in human term placenta.
Enhancement of human hepatocyte growth factor production by interleukin-1 alpha and -1 beta and tumor necrosis factor-alpha by fibroblasts in culture.
Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure.
Kilby MD, Afford S, Li XF, Strain AJ, Ahmed A, Whittle MJ
Growth factors (Chur, Switzerland) 1996;13(1-2):133-9
Growth factors (Chur, Switzerland) 1996;13(1-2):133-9
Enhancement of human hepatocyte growth factor production by interleukin-1 alpha and -1 beta and tumor necrosis factor-alpha by fibroblasts in culture.
Tamura M, Arakaki N, Tsubouchi H, Takada H, Daikuhara Y
The Journal of biological chemistry 1993 Apr 15;268(11):8140-5
The Journal of biological chemistry 1993 Apr 15;268(11):8140-5
Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure.
Gohda E, Tsubouchi H, Nakayama H, Hirono S, Sakiyama O, Takahashi K, Miyazaki H, Hashimoto S, Daikuhara Y
The Journal of clinical investigation 1988 Feb;81(2):414-9
The Journal of clinical investigation 1988 Feb;81(2):414-9
No comments: Submit comment
No validations: Submit validation data